Simplex Trading
NAVB

Simplex Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Simplex Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,500
Closed -$7K – 11540
2022
Q2 		$7K Sell
10,500
-18,100
-63% -$15.4K ﹤0.01% 8682
2022
Q1 		$22K Sell
28,600
-21,600
-43% -$19.8K ﹤0.01% 8184
2021
Q4 		$50K Sell
50,200
-17,800
-26% -$25.1K ﹤0.01% 7284
2021
Q3 		$122K Hold
68,000
– – ﹤0.01% 6344
2021
Q2 		$124K Buy
68,000
+67,879
+56,098% +$120K ﹤0.01% 6426
2021
Q1 		$24K Sell
121
-49
-29% -$115 ﹤0.01% 7332
2020
Q4 		$36K Sell
170
-171
-50% -$403 ﹤0.01% 6516
2020
Q3 		$92K Buy
341
+161
+89% +$578 ﹤0.01% 5007
2020
Q2 		$70K Buy
+180
New +$344 ﹤0.01% 5177
2020
Q1 		– Sell
-21
Closed -$2K – 8740
2019
Q4 		$2K Hold
21
– – ﹤0.01% 7041
2019
Q3 		$1K Buy
+21
New +$13 ﹤0.01% 7142
2016
Q4 		– Sell
-2
Closed -$1K – 6925
2016
Q3 		$1K Sell
2
-2
-50% -$25 ﹤0.01% 5576
2016
Q2 		$3K Buy
4
+1
+33% +$20 ﹤0.01% 4776
2016
Q1 		$1K Buy
+3
New +$58 ﹤0.01% 5350
2015
Q4 		– Sell
-10
Closed -$1K – 6522
2015
Q3 		$1K Hold
10
– – ﹤0.01% 5279
2015
Q2 		$11K Hold
10
– – ﹤0.01% 3019
2015
Q1 		$11K Buy
10
+8
+400% +$271 ﹤0.01% 2908
2014
Q4 		$1K Buy
+2
New +$55 ﹤0.01% 4423

Other funds holding NAVB

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Simplex Trading's NAVB Position: Q2 2023 in Review

Simplex Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 28,416 shares — an estimated $4.53K sold.

Simplex Trading first reported a position in NAVB in Q4 2014 and held it in 17 quarters. The position peaked at $73K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

  • Simplex Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 28,416 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $4.53K.
  • Simplex Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2014 and held it in 17 quarters.
  • Simplex Trading's Navidea Biopharmaceuticals Inc. position peaked at $73K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.